June 27, 2025
CorMedix Inc. Announces Proposed Public Offering of Common Stock
BERKELEY HEIGHTS, N.J., June 26, 2025 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and…
Pharmaceuticals, Biotechnology and Life Sciences
BERKELEY HEIGHTS, N.J., June 26, 2025 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and…
Company to host a conference call to discuss results at 8:00am EDT on June 30, 2025 Boca Raton, Florida, June…
Introducing Ice Cream Man, Skywalker OG Gold Edition, Red Velvet, Gold Cash Gold Edition, and Jedi BreathMADISON, Wis., June 26,…
The new branding showcases the Company’s innovative vision for the future and mission to redefine the retina experienceBEDFORD, Mass., June…
Percheron Therapeutics obtains exclusive worldwide rights to Hummingbird Bioscience’s anti-VISTA mAb for further clinical development Hummingbird Bioscience stands to receive…
Company to host Investor Webcast on Thursday, June 26, 2025, at 8:30 am E.T.GAITHERSBURG, Md., June 25, 2025 (GLOBE NEWSWIRE)…
VANCOUVER, British Columbia, June 25, 2025 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) (“Rakovina” or the “Company”),…
TORONTO, June 25, 2025 (GLOBE NEWSWIRE) — Psyence Group Inc. (CSE: PSYG) (“Psyence” or the “Company”), a life science biotechnology…
CAMBRIDGE, Mass., June 25, 2025 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of…
-Vor Bio receives ex-Greater China rights to develop and commercialize telitacicept, a novel, dual-target recombinant fusion protein in global Phase…